547 related articles for article (PubMed ID: 28213094)
21. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.
Sun YP; Oh SF; Uddin J; Yang R; Gotlinger K; Campbell E; Colgan SP; Petasis NA; Serhan CN
J Biol Chem; 2007 Mar; 282(13):9323-9334. PubMed ID: 17244615
[TBL] [Abstract][Full Text] [Related]
22. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
[TBL] [Abstract][Full Text] [Related]
23. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.
Halade GV; Kain V; Serhan CN
FASEB J; 2018 Jul; 32(7):3717-3729. PubMed ID: 29455574
[TBL] [Abstract][Full Text] [Related]
24. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.
Harrison JL; Rowe RK; Ellis TW; Yee NS; O'Hara BF; Adelson PD; Lifshitz J
Brain Behav Immun; 2015 Jul; 47():131-40. PubMed ID: 25585137
[TBL] [Abstract][Full Text] [Related]
25. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.
Lance KD; Chatterjee A; Wu B; Mottola G; Nuhn H; Lee PP; Sansbury BE; Spite M; Desai TA; Conte MS
J Biomed Mater Res A; 2017 Jan; 105(1):31-41. PubMed ID: 27508346
[TBL] [Abstract][Full Text] [Related]
26. The utilisation of resolvins in medicine and tissue engineering.
Blaudez F; Ivanovski S; Fournier B; Vaquette C
Acta Biomater; 2022 Mar; 140():116-135. PubMed ID: 34875358
[TBL] [Abstract][Full Text] [Related]
27. Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae.
Croasdell A; Lacy SH; Thatcher TH; Sime PJ; Phipps RP
J Immunol; 2016 Mar; 196(6):2742-52. PubMed ID: 26843331
[TBL] [Abstract][Full Text] [Related]
28. Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.
Cox R; Phillips O; Fukumoto J; Fukumoto I; Parthasarathy PT; Arias S; Cho Y; Lockey RF; Kolliputi N
Am J Respir Cell Mol Biol; 2015 Sep; 53(3):422-35. PubMed ID: 25647402
[TBL] [Abstract][Full Text] [Related]
29. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
30. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses.
Rogerio AP; Haworth O; Croze R; Oh SF; Uddin M; Carlo T; Pfeffer MA; Priluck R; Serhan CN; Levy BD
J Immunol; 2012 Aug; 189(4):1983-91. PubMed ID: 22802419
[TBL] [Abstract][Full Text] [Related]
31. Oral omega-3 fatty acids promote resolution in chemical peritonitis.
Chacon AC; Phillips BE; Chacon MA; Brunke-Reese D; Kelleher SL; Soybel DI
J Surg Res; 2016 Nov; 206(1):190-198. PubMed ID: 27916361
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the inflammatory response to chitosan through M2 macrophage polarization using pro-resolution mediators.
Vasconcelos DP; Costa M; Amaral IF; Barbosa MA; Águas AP; Barbosa JN
Biomaterials; 2015 Jan; 37():116-23. PubMed ID: 25453942
[TBL] [Abstract][Full Text] [Related]
33. Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling.
Elajami TK; Colas RA; Dalli J; Chiang N; Serhan CN; Welty FK
FASEB J; 2016 Aug; 30(8):2792-801. PubMed ID: 27121596
[TBL] [Abstract][Full Text] [Related]
34. Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.
Filiberto AC; Ladd Z; Leroy V; Su G; Elder CT; Pruitt EY; Hensley SE; Lu G; Hartman JB; Zarrinpar A; Sharma AK; Upchurch GR
FASEB J; 2022 Nov; 36(11):e22579. PubMed ID: 36183323
[TBL] [Abstract][Full Text] [Related]
35. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis.
Serhan CN; Gotlinger K; Hong S; Arita M
Prostaglandins Other Lipid Mediat; 2004 Apr; 73(3-4):155-72. PubMed ID: 15290791
[TBL] [Abstract][Full Text] [Related]
36. Dual delivery of IL-10 and AT-RvD1 from PEG hydrogels polarize immune cells towards pro-regenerative phenotypes.
Sok MCP; Baker N; McClain C; Lim HS; Turner T; Hymel L; Ogle M; Olingy C; Palacios JI; Garcia JR; Srithar K; García AJ; Qiu P; Botchwey EA
Biomaterials; 2021 Jan; 268():120475. PubMed ID: 33321293
[TBL] [Abstract][Full Text] [Related]
37. Spatially localized recruitment of anti-inflammatory monocytes by SDF-1α-releasing hydrogels enhances microvascular network remodeling.
Krieger JR; Ogle ME; McFaline-Figueroa J; Segar CE; Temenoff JS; Botchwey EA
Biomaterials; 2016 Jan; 77():280-90. PubMed ID: 26613543
[TBL] [Abstract][Full Text] [Related]
38. Resolvin D1: A key endogenous inhibitor of neuroinflammation.
Roohbakhsh A; Etemad L; Karimi G
Biofactors; 2022 Sep; 48(5):1005-1026. PubMed ID: 36176016
[TBL] [Abstract][Full Text] [Related]
39. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.
Eickmeier O; Seki H; Haworth O; Hilberath JN; Gao F; Uddin M; Croze RH; Carlo T; Pfeffer MA; Levy BD
Mucosal Immunol; 2013 Mar; 6(2):256-66. PubMed ID: 22785226
[TBL] [Abstract][Full Text] [Related]
40. Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy.
Turner TC; Sok MCP; Hymel LA; Pittman FS; York WY; Mac QD; Vyshnya S; Lim HS; Kwong GA; Qiu P; Botchwey EA
Sci Adv; 2020 Oct; 6(44):. PubMed ID: 33127670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
